Abstract:Growing attentions have been focused on natural antitumor drugs. Recently, a novel and potent antitumor drug Cheliensisin A (GC-51) with broad-spectrum efficiency has been developed. However, due to its poor water solubility and chemical instability, choosing the appropriate dosage form is of great significance. This study aimed at developing a lyophilized submicron emulsion for GC-51 and further improving the therapeutic index of the drug. The resultant lyophilized GC-51 submicron emulsion was much more stable than its solution, which can be stored for years without significant change on physicochemical properties. And its solubility was increased from 6.74+/-0.14 to 2.00+/-0.10 mg mL(-1). The 50% inhibitory concentration IC50 values were calculated from growth curves by MTT assay on various tumor cell lines. Compared with the IC50 of GC-51 crude drug, that of lyophilized GC-51 submicron emulsion decreased from 24.04+/-1.97 to 8.23+/-1.84 microg mL(-1) on HepG2, and from 31.08+/-2.56 to 10.85+/-2.09 microg mL(-1) on CT-26, from 17.90+/-1.83 to 7.49+/-1.87 microg mL(-1) on HeLa and from 16.38+/-2.41 to 10.13+/-2.12 microg mL(-1) on A549, respectively. In the time-dependent assay of tumor cell viability, lyophilized GC-51 submicron emulsion exhibited significantly lower inhibition rate in the initial action times, but increased gradually afterwards. That means lyophilized submicron emulsion as the vector for GC-51 had some protective and delayed release effect. Further, the in vivo therapeutic efficacy was measured in pulmonary metastasis of colon cancer-bearing BALB/c mice model. An obvious enhanced antitumor activity was observed after administration of lyophilized GC-51 submicron emulsion (P<0.05), which increased from 22.78+/-3.5 to 41.42+/-4.2% compared with GC-51 injection. And the life span of tumor-bearing mice in lyophilized GC-51 submicron emulsion group was significantly longer than that of the mice in GC-51 injection and normal saline groups. Compared with crude drug, the lyophilized GC-51 submicron emulsion showed a significantly higher antitumor efficiency both in vivo and in vitro, suggesting a potential application in tumor chemotherapy.

Optimization of Freezing-dried Cheliensisin A Submicron Emulsion for Intravenous Injection by Central Composite Design-Response Surface Methodology

Optimization of the formulation of tanshinone ⅡA freezing-drized submicron emulsion by Central composite design-response surface method

Optimization of the Formulation of Polyene Phosphatidylcholine Injection by Central Composite Design-Response Surface Method

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Optimization of preparation technology and formulation of pingyangmycin liposomes by central composite design and response surface method

Optimization of the technological process to prepare Dexamethasone acetate lipid nanoparticles using central composite design-response surface methodology

Optimization of protein-loaded nano-liposomes formulation by central composite design and response surface method

Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology

Optimization of BSA Freeze-Dried Liposome Prescription by Response Surface Methodology

Preparation and characterization of clopidogrel bisulfate submicron emulsion for injection

Preparation of Aprepitant Emulsion for Intravenous Injection

Optimization of Pulmonary Targeting Dipyridamole Liposomes by Central Composite Design-Response Surface Methodology

Application of Central Composite Design-Based Response Surface Methodology in Optimization of the Preparation Process of Sanguinarine Chitosan Microspheres

Optimization of Self-Microemulsions Drug Delivery System of TPG by Central Composite Design Response Surface Methodology

Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats.

Lyophilized Cheliensisin A Submicron Emulsion for Intravenous Injection: Characterization, in Vitro and in Vivo Antitumor Effect

Optimization of demulsification of soybean emulsion with freeze-microwave thaw by response surface methodology

Process Optimization of Chitosan Microspheres Preparation Technology by Uniform Design

Optimization of Preparation of Estradiol Polylactic-Co-Glycollic Microspheres by Central Composite Design

Optimization of the Formulation of Breviscapine Injection

Preperation and Quality Evaluation of Dehydroandrographolide Self-emulsifying Formulation